Arkolith/Insider Trading/DNTH/Form 4

Garcia Marino

CEO AND PRESIDENT, DirectorDianthus Therapeutics, Inc. /DE/ (DNTH) · full profile →Form 4 · filed Mar 17, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 16, 2026Option exercise(M)60K$6.70$400K60K
Mar 16, 2026Option exercise(M)6K$17.88$100K65K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 16, 2026Option exercise(M)60K—$041
Mar 16, 2026Option exercise(M)6K—$0269K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001669866-26-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML